Ankasa Regenerative Therapeutics
CA - La JollaBiotechnology
Focus: Ankasa is a La Jolla-based regenerative medicine biotech focused on proprietary WNT stem cell activators for surgical applications, operating as a public company in the cell therapy space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$19M
Open Jobs
0
About Ankasa Regenerative Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Ankasa Regenerative Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ART352-L
Degenerative SpondylolisthesisClinical Trials (1)
NCT04378543Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
Phase 1/2Help build intelligence for Ankasa Regenerative Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.